NASDAQ · Medical Instruments & Supplies · USD
Anbio Biotechnology (NNNN) Stock Analysis
Anbio Biotechnology (NNNN) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
NNNN Key Statistics
As of Oct 21, 2026Trading
- Open
- $3.64
- Previous Close
- $3.73
- Day's Range
- 3.53–4.00
- 52-Week Range
- 3.09–44.73
- Volume
- 113.93K
Valuation
- Market Cap
- $163.28M
- P/E Ratio
- 24.80
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 18.88
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.15
Financials (FY)
- Revenue (FY)
- $8.65M+5.64%
- Net Income (FY)
- $6.40M+169.86%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 74.06%
- Shares Outstanding
- 43.89M
- 1-Year Return
- −87.97%
Dividend and dates
- Avg Volume
- 151.25K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, NNNN closed at $3.72, −87.97% over 1 year.
Anbio Biotechnology (NNNN) has a market capitalization of $163.28M.
In fiscal 2025, NNNN reported revenue of $8.65M.
NNNN Stock Return by Calendar Year
Anbio Biotechnology (NNNN) return since Feb 2025: what $10,000 became
- 1 year
- $10,000 $1,203
- −87.97%
- Since Feb 2025
- $10,000 $6,447
- −35.53%
If you had invested $10,000 in Anbio Biotechnology (NNNN) at the close on February 19, 2025, the earliest close on record here, it would have been worth $6,447 at the close on October 21, 2026: −35.53% in total, −23.15% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −87.63% |
| 2025 (partial year) | +421.14% |
As of October 21, 2026.
NNNN Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $8.65M | $6.40M | 74.1% |
| 2024 | $8.19M | $2.37M | 29.0% |
| 2023 | $6.71M | $2.25M | 33.6% |
| 2022 | $23.54M | $10.01M | 42.5% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $8.65M | $7.54M | $5.77M | $6.40M | 74.1% |
| 2024 | $8.19M | $5.89M | $2.00M | $2.37M | 29.0% |
| 2023 | $6.71M | $3.36M | $1.96M | $2.25M | 33.6% |
| 2022 | $23.54M | $12.56M | $10.20M | $10.01M | 42.5% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
NNNN Valuation vs Medical Instruments & Supplies Median
Median of 50 stocks| Metric | NNNN | Medical Instruments & Supplies median | vs median |
|---|---|---|---|
| P/E | 24.80 | 31.19 | 20% below |
| P/S ratio | 18.88 | 2.60 | 7.3x the median |
| Profit margin | 74.06% | 1.62% | 72.4 pts above |
Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Instruments & Supplies Stocks
Intuitive Surgical, Inc.
$151.25B
BDXBecton, Dickinson and Company
$52.79B
MDLNMedline Inc.
$47.51B
RMDResMed Inc.
$34.63B
ALCAlcon Inc.
$32.60B
WSTWest Pharmaceutical Services, Inc.
$27.69B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B